Washington University Therapeutics (WT) CRS (Site # 2101) — St Louis, Missouri

Washington University Therapeutics (WT) CRS (Site # 2101) is a clinical research site located in St Louis, Missouri, United States 63110-1010.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University Therapeutics (WT) CRS (Site # 2101) has participated in 1 clinical trials.

Therapeutic areas: HIV-1-infection, Elevated Cardiovascular Risk.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University Therapeutics (WT) CRS (Site # 2101)?

Washington University Therapeutics (WT) CRS (Site # 2101) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University Therapeutics (WT) CRS (Site # 2101) conducted?

Washington University Therapeutics (WT) CRS (Site # 2101) has 1 clinical trials on record. Their work covers HIV-1-infection, Elevated Cardiovascular Risk.

Is Washington University Therapeutics (WT) CRS (Site # 2101) accredited by Crixeo Health?

Washington University Therapeutics (WT) CRS (Site # 2101) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University Therapeutics (WT) CRS (Site # 2101)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.